Assessing Plexus (PLXS) Valuation After Earnings Beat Guidance Update And Buyback Activity

Simply Wall St

Wed, February 11, 2026 at 11:09 AM GMT+9 3 min read

In this article:

PLXS

-1.13%

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE.

Plexus (PLXS) has attracted investors’ attention after reporting first quarter earnings, issuing fresh guidance for the next quarter, and updating its ongoing share repurchase activity, giving the market several new data points to assess.

See our latest analysis for Plexus.

The earnings beat, fresh guidance and buyback update come after a strong run in the share price, with a 30.61% 1 month share price return and a 40.86% 3 month share price return. The 1 year total shareholder return of 46.28% and 5 year total shareholder return of 150.18% point to momentum that has rewarded longer term holders.

If Plexus has your attention, it can be helpful to broaden your watchlist and see what else is working in the market through our screener of 23 top founder-led companies.

With the stock now trading slightly above the average analyst target and Plexus completing a modest buyback, you have to ask yourself: is there still value on the table here, or is the market already pricing in future growth?

Most Popular Narrative: 2.6% Overvalued

With Plexus closing at $206.00 against a narrative fair value of about $200.80, the current price sits slightly ahead of that central estimate, which hinges on how convincingly the company can turn sector opportunities into sustained earnings power.

The company’s increasing success in winning programs in high-margin, complex sectors such as healthcare/life sciences, aerospace, and defense (including strong defense pipeline in Europe and record sector wins), is shifting the revenue mix toward segments with higher pricing power and more stable, long-term contracts, this should positively impact both revenue consistency and net margin expansion.

Read the complete narrative.

Curious what kind of revenue runway and margin profile sit behind that view, and how long Plexus would need to hold those levels for this valuation to stack up? The full narrative lays out the earnings path, the assumed profitability step up, and the pricing multiple it all needs to support.

Result: Fair Value of $200.80 (OVERVALUED)

Have a read of the narrative in full and understand what’s behind the forecasts.

However, there is still real execution risk, especially if large customer orders are delayed or new facilities like Malaysia weigh on margins longer than analysts currently assume.

Find out about the key risks to this Plexus narrative.

Build Your Own Plexus Narrative

If you look at the numbers and reach a different conclusion, or simply prefer to test your own assumptions, you can build a personalised Plexus narrative in just a few minutes with Do it your way.

Story Continues  

A great starting point for your Plexus research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.

Looking for more investment ideas?

If Plexus has sparked your interest, do not stop there. Use this momentum to widen your opportunity set with a few focused stock ideas.

Target resilient compounding potential by scanning companies with 51 high quality undervalued stocks that pair quality fundamentals with prices that may not fully reflect their underlying strength.

Prioritise income by checking out 14 dividend fortresses that aim to combine higher yields with businesses focused on maintaining regular shareholder payouts.

Reduce portfolio shocks by reviewing 83 resilient stocks with low risk scores that score well on financial stability and business risk measures.

_ This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._

Companies discussed in this article include PLXS.

Have feedback on this article? Concerned about the content? Get in touch with us directly._ Alternatively, email editorial-team@simplywallst.com_

Terms and Privacy Policy

Privacy Dashboard

More Info